Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $3.57 in the prior trading day, Corvus Pharmaceuticals Inc (NASDAQ: CRVS) closed at $3.35, down -6.03%. In other words, the price has decreased by -$6.03 from its previous closing price. On the day, 0.71 million shares were traded.
Ratios:
Our goal is to gain a better understanding of CRVS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.54 and its Current Ratio is at 1.54. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on January 02, 2025, initiated with a Buy rating and assigned the stock a target price of $11.
On August 18, 2023, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $7.
Stock Price History:
Over the past 52 weeks, CRVS has reached a high of $10.00, while it has fallen to a 52-week low of $1.43. The 50-Day Moving Average of the stock is -9.38%, while the 200-Day Moving Average is calculated to be -35.97%.
Shares Statistics:
A total of 67.90M shares are outstanding, with a floating share count of 46.66M. Insiders hold about 31.51% of the company’s shares, while institutions hold 34.13% stake in the company.
